Lundquist Institute Secures $9 Million for Regenerative Medicine Center
Torrance, Friday, 31 October 2025.
The Lundquist Institute has received $9 million to establish the South Los Angeles Community Center of Excellence for Regenerative Medicine, focusing on expanding access to advanced therapies and improving clinical research infrastructure.
Transformative Impact on Healthcare in South Los Angeles
The Lundquist Institute’s recent funding of $9 million from the California Institute for Regenerative Medicine (CIRM) marks a significant step toward transforming healthcare delivery in South Los Angeles. The establishment of the South Los Angeles Community Center of Excellence for Regenerative Medicine (SoLA-CCERM) aims to expand access to cutting-edge regenerative therapies to over 750,000 patients. This initiative addresses long-standing inequities in clinical trial participation by integrating advanced gene and cell-based treatments into the community’s healthcare options [1].
Enhancing Research Infrastructure and Education
SoLA-CCERM is poised to significantly enhance the clinical research infrastructure in the region. By focusing on in vivo gene therapies within an ambulatory setting, the center aims to deliver innovative treatments efficiently. Additionally, the establishment of SoLA-CCERM will create numerous training and career opportunities in regenerative medicine, supported by partnerships with educational institutions and healthcare organizations. Such efforts not only advance medical research but also contribute to workforce development in the healthcare sector [1].
Community Engagement and Future Prospects
Community engagement is a cornerstone of the center’s operations, with active involvement from local organizations and patient advocacy groups. This collaborative approach enhances education, outreach, and clinical trial participation, ensuring that the community benefits from the latest medical advancements. By working closely with CIRM’s Alpha Clinic Network, SoLA-CCERM will connect local patients with statewide clinical trials, further democratizing access to experimental therapies [1].
Long-term Vision for Regenerative Medicine
The long-term vision of SoLA-CCERM is to position itself as a leader in regenerative medicine, not only in California but globally. By integrating research, education, and community health initiatives, the center seeks to deliver lasting improvements in health outcomes. This initiative represents a broader trend in digital health innovations and underscores the importance of investing in research infrastructure and community engagement to drive systemic change in healthcare delivery [1].